GENERIC IMATINIB: A COST-EFFECTIVE OPTION?

The introduction of off-brand imatinib represents a notable opportunity for patients battling chronic myeloid leukemia and other illnesses. Original brand-name imatinib, commonly known as Gleevec, carries a high price label, frequently making it accessibility for some individuals. Common versions